A. Chandrasekharan

发表

A cross-sectional audit of distress in patients undergoing adjuvant therapy or follow-up in central nervous system malignancies.

J. Deodhar, A. Bhattacharjee, V. Patil, 2018, Neuro-oncology practice.

Distress Management in Patients With Head and Neck Cancer Before Start of Palliative Chemotherapy: A Practical Approach

J. Deodhar, K. Prabhash, S. Chakraborty, 2018, Journal of global oncology.

Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer.

G. Batist, J. Gutheil, M. Nair, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patients

A. Bhattacharjee, K. Prabhash, V. Noronha, 2018, South Asian journal of cancer.

“Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia”

A. Chandrasekharan, S. Banavali, J. Ghosh, 2019, Breast.

Neoadjuvant chemotherapy in technically unresectable adenocarcinoma of parotid

K. Prabhash, V. Noronha, V. Rangarajan, 2019, South Asian Journal of Cancer.

Efficacy of Second-Line Pemetrexed-Carboplatin in EGFR-Activating Mutation-Positive NSCLC: Does Exon 19 Deletion Differ from Exon 21 Mutation?

Rajiv Kumar, A. Mahajan, A. Bhattacharjee, 2017, Chemotherapy research and practice.

Adolescent–adult nonmetastatic Ewing sarcoma—Experience from a large developing country

K. Prabhash, Sudeep Gupta, V. Noronha, 2021, Pediatric blood & cancer.

Activation of phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin pathway and response to everolimus in endocrine receptor-positive metastatic breast cancer – A retrospective pilot analysis and viewpoint

R. Badwe, Sudeep Gupta, A. Chandrasekharan, 2017, South Asian Journal of Cancer.

Weekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer

K. Prabhash, V. Noronha, A. Joshi, 2016, South Asian Journal of Cancer.

Expectations and preferences for palliative chemotherapy in head and neck cancers patients.

J. Deodhar, A. Bhattacharjee, K. Prabhash, 2016, Oral oncology.

Metronomic palliative chemotherapy in maxillary sinus tumor

K. Prabhash, V. Patil, A. Joshi, 2016, South Asian Journal of Cancer.

Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial.

S. Kannan, P. Pai, A. Bhattacharjee, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation.

P. Pai, A. Bhattacharjee, S. Nair, 2022, Oral oncology.

Long term toxicity and tolerance of concurrent docetaxel with radiotherapy in cisplatin-ineligible head and neck cancer patients.

K. Prabhash, V. Noronha, V. Patil, 2022, Oral oncology.

Scalp Cooling for Chemotherapy-induced Alopecia Prevention: “Fantasy Turned into Reality”

A. Chandrasekharan, J. Bajpai, 2020, Indian Journal of Medical and Paediatric Oncology.

Low, fixed dose defibrotide in management of hepatic veno-occlusive disease post stem cell transplantation.

A. Chandrasekharan, B. Bagal, N. Khattry, 2017, Hematology/oncology and stem cell therapy.

Eschar: an important clue to diagnosis

A. Chandrasekharan, B. Sharma, Naveen Kumar, 2013, BMJ Case Reports.

Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer

S. Kannan, A. Mahajan, A. Bhattacharjee, 2019, EClinicalMedicine.

Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed–carboplatin chemotherapy

Rajiv Kumar, A. Mahajan, A. Bhattacharjee, 2017, Ecancermedicalscience.

Fatigue: Affliction or alleviation? The need to travel further down the rabbit hole

A. Chandrasekharan, M. Anuja, 2022, Cancer Research, Statistics, and Treatment.

Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancer

Rajiv Kumar, A. Mahajan, A. Bhattacharjee, 2019, Oncotarget.

Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial.

A. Mahajan, A. Bhattacharjee, K. Prabhash, 2020, The Lancet. Global health.

Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer.

A. Mahajan, M. Mahimkar, A. Bhattacharjee, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer

P. Chaturvedi, S. Kannan, A. Mahajan, 2019, Cancer.

Quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of a Phase III randomized trial to compare the benefit of gefitinib versus pemetrexed/carboplatin for epidermal growth factor receptor-mutated non-small cell lung cancer

A. Mahajan, A. Bhattacharjee, K. Prabhash, 2019, Cancer Research, Statistics, and Treatment.

Tyrosine Kinase Inhibitor versus Physician Choice Chemotherapy in Second-Line Epidermal Growth Factor Receptor Mutation Non-Small Cell Lung Cancer: Post hoc Analysis of Randomized Control Trial

Rajiv Kumar, A. Mahajan, A. Bhattacharjee, 2018, Indian Journal of Medical and Paediatric Oncology.

Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma

Rajiv Kumar, A. Mahajan, A. Bhattacharjee, 2017, ESMO Open.

Outcomes in Treatment-Naïve Patients With Metastatic Extremity Osteosarcoma Treated With OGS-12, a Novel Non–High-Dose Methotrexate–Based, Dose-Dense Combination Chemotherapy, in a Tertiary Care Cancer Center

Sudeep Gupta, A. Chandrasekharan, A. Karpe, 2018, Journal of global oncology.

Driver Mutations in Lung Cancer—Mapping the Way Forward

A. Chandrasekharan, 2022, South Asian Journal of Cancer.

Osteosarcoma journey over two decades in India: Small steps, big changes

Sudeep Gupta, A. Chandrasekharan, B. Rekhi, 2019, Pediatric blood & cancer.

Impact of COVID-19 on cancer care in India: a cohort study

R. Nair, A. Das, R. Badwe, 2021, The Lancet Oncology.

Demographics, Pattern of Care, and Outcome Analysis of Malignant Melanomas - Experience From a Tertiary Cancer Centre in India

Rajiv Kumar, K. Prabhash, Sudeep Gupta, 2021, Frontiers in Oncology.

Long-term survival outcomes of technically unresectable carcinoma maxilla postinduction chemotherapy

P. Pai, K. Prabhash, V. Noronha, 2018, South Asian Journal of Cancer.

865MO RMAC study: A randomized study evaluating the efficacy of metronomic adjuvant chemotherapy in patients with recurrent head and neck cancers post salvage surgery, not eligible for re-irradiation

A. Bhattacharjee, K. Prabhash, V. Noronha, 2021, Annals of Oncology.

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer

A. Mahajan, M. Mahimkar, P. Pai, 2020, Oncotarget.

Outcomes of Ewing sarcoma in adults over 40 years of age from a low-middle income country

K. Prabhash, Sudeep Gupta, V. Noronha, 2022, Ecancermedicalscience.

Antiemetic prophylaxis with temozolomide: an audit from a tertiary care center.

A. Bhattacharjee, V. Patil, M. Malhotra, 2019, Neuro-oncology practice.

Salvage surgery in head and neck cancer: Does it improve outcomes?

A. Mahajan, P. Pai, A. Bhattacharjee, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen 'OGS-12'.

Sudeep Gupta, A. Chandrasekharan, V. Talreja, 2017, European journal of cancer.

Palliative chemotherapy in carcinoma nasopharynx

K. Prabhash, V. Noronha, V. Patil, 2019, South Asian Journal of Cancer.

A review of the pharmacokinetic and polymorphic profiles of pemetrexed and their influence on its activity

A. Chandrasekharan, Maria L. Joseph, Muhammed Fayiz, 2022, Cancer Research, Statistics, and Treatment.

Aspiration pneumonia in head and neck cancer patients undergoing concurrent chemoradiation from India: Findings from a post hoc analysis of a phase 3 study

K. Prabhash, V. Noronha, V. Patil, 2021, Cancer medicine.

Mebendazole plus lomustine or temozolomide in patients with recurrent glioblastoma: A randomised open-label phase II trial

A. Mahajan, T. Gupta, N. Pande, 2022, EClinicalMedicine.

Incidence and impact of Dihydropyrimidine dehydrogenase gene mutation on neoadjuvant chemotherapy in head and neck cancers.

K. Prabhash, V. Noronha, V. Patil, 2017, Oral Oncology.

Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancer.

A. Mahajan, S. Arya, A. Bhattacharjee, 2017, Oral oncology.

Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?

Rajiv Kumar, A. Mahajan, A. Bhattacharjee, 2018, Lung India : official organ of Indian Chest Society.

Fatal complications of Plasmodium vivax malaria: A series of three case reports

A. Chandrasekharan, B. Sharma, Naveen Kumar, 2013 .

Steroids and immunotherapy: The good, bad, or the ugly?

A. Chandrasekharan, K. Sreelesh, K. Gangadharan, 2020, Cancer Research, Statistics, and Treatment.

Adolescent–adult nonmetastatic Ewing sarcoma—Experience from a large developing country

K. Prabhash, Sudeep Gupta, V. Noronha, 2021, Pediatric blood & cancer.

Shadow study: randomized comparison of clinic with video follow-up in glioma undergoing adjuvant temozolomide therapy

T. Gupta, V. Patil, N. Pande, 2018, CNS oncology.

Activation of phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin pathway and response to everolimus in endocrine receptor-positive metastatic breast cancer – A retrospective pilot analysis and viewpoint

Sudeep Gupta, A. Chandrasekharan, A. Ramaswamy, 2017, South Asian Journal of Cancer.

Hypothyroidism post-chemoradiation on outcomes in head-and-neck cancer

A. Bhattacharjee, K. Prabhash, V. Noronha, 2018, Cancer Research, Statistics, and Treatment.

Quality of life without toxicity or symptoms analysis of a randomized controlled clinical trial comparing efficacy of cabazitaxel versus docetaxel in recurrent head and neck cancer

A. Mahajan, A. Bhattacharjee, K. Prabhash, 2018, Cancer Research, Statistics, and Treatment.